Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00343434
What this trial is testing

Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight

Who this might be right for
Breast CancerObesity
Wake Forest University Health Sciences 25
Testing effectiveness (Phase 2)Looking for participantsNCT06601309
What this trial is testing

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01818063
What this trial is testing

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Large-scale testing (Phase 3)UnknownNCT00297570
What this trial is testing

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Who this might be right for
Leukemia, Myeloid, Philadelphia-Positive
Sheba Medical Center 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722172
What this trial is testing

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center 55
Not applicableLooking for participantsNCT07829081
What this trial is testing

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Who this might be right for
Quality of Life (QOL)Mismatch Repair Deficient Colorectal CancerMicrosatellite Instability-High Colorectal Cancer+8 more
University Hospital, Basel, Switzerland 234
Not applicableStudy completedNCT02575612
What this trial is testing

Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 50
Not applicableNot Yet RecruitingNCT07500129
What this trial is testing

Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

Who this might be right for
Breast CancerInvasive Breast CarcinomaExosomal microRNA+2 more
Atlas University 60
Post-approval studies (Phase 4)Study completedNCT01243489
What this trial is testing

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Large-scale testing (Phase 3)Active Not RecruitingNCT04229979
What this trial is testing

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Who this might be right for
Acute Myeloid Leukemia
Sellas Life Sciences Group 127
Not applicableStudy completedNCT01430663
What this trial is testing

Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples

Who this might be right for
Invasive Aspergillosis
Heidelberg University 87
Testing effectiveness (Phase 2)Study completedNCT00093639
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Who this might be right for
Leukemia
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01227577
What this trial is testing

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 128
Testing effectiveness (Phase 2)Study completedNCT01850004
What this trial is testing

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 84
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04335669
What this trial is testing

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Who this might be right for
Breast CancerTriple Negative Breast Neoplasms
Lund University Hospital 325
Large-scale testing (Phase 3)Study completedNCT01648894
What this trial is testing

Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Assistance Publique - Hôpitaux de Paris 265
Testing effectiveness (Phase 2)Looking for participantsNCT06647680
What this trial is testing

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Who this might be right for
Rectal Cancer Patients
The Affiliated Hospital of Qingdao University 35
Testing effectiveness (Phase 2)Study completedNCT01914900
What this trial is testing

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Who this might be right for
Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Not applicableLooking for participantsNCT02306096
What this trial is testing

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Who this might be right for
Breast Neoplasms
Lund University 20,000
Next Page